M. Ray

A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies

Johannes R. Kratz, Jianxing He, Stephen K. Van Den Eeden et al. · The Lancet · 2012 · 331 citations

Medicine, Molecular Biology, Oncology +15

A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma

Dan J. Raz, M. Ray, Jae Y. Kim et al. · Clinical Cancer Research · 2008 · 86 citations

Medicine, Biostatistics, Oncology +17

Inhibition of Hsp90 Leads to Cell Cycle Arrest and Apoptosis in Human Malignant Pleural Mesothelioma

Junichi Okamoto, Iwao Mikami, Yuichi Tominaga et al. · Journal of Thoracic Oncology · 2008 · 59 citations · Full text

Medicine, Cell Biology, Oncology +13

Analytical Validation of a Practical Molecular Assay Prognostic of Survival in Nonsquamous Non–Small Cell Lung Cancer

Johannes R. Kratz, Patrick T. Tham, Michael S. Mulvihill et al. · Diagnostic Molecular Pathology · 2013 · 24 citations

Medicine, Molecular Medicine, Oncology +15

Downregulation of EMX2 is Associated with Clinical Outcomes in Lung Adenocarcinoma Patients

Junichi Okamoto, Johannes R. Kratz, Tomomi Hirata et al. · Clinical Lung Cancer · 2011 · 24 citations

Medicine, Cancer Biology, Oncology +11